Status:
RECRUITING
Phenotypic Classification of FMR With CMR
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Nonischemic Congestive Cardiomyopathy
Functional Mitral Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
The goal of the current research is to develop personalized risk prediction for functional mitral regurgitation (FMR) patients through explainable unsupervised phenomapping enriched with advanced card...
Detailed Description
Functional mitral regurgitation (FMR) portends a bleak prognosis and is a common consequence of ischemic and non-ischemic cardiomyopathy (ICM, NICM), where adverse annular and left ventricular (LV) re...
Eligibility Criteria
Inclusion
- 1 CMR LVEF \<55% 2.FMR Fraction\>20% or echo criteria consistent with at least moderate mitral regurgitation with adequate image quality
Exclusion
- \>moderate aortic regurgitation/stenosis,
- \<18 years of age,
- acute myocarditis,
- eGFR\<15
- HCM
- cardiac amyloidosis/sarcoidosis
- prior mitral valve intervention
- myocardial infarction within 8 weeks of CMR
Key Trial Info
Start Date :
August 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT05965258
Start Date
August 29 2023
End Date
December 31 2028
Last Update
October 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195